Landscape of BRCA1 and BRCA2 germline, somatic, and reversion alterations detectable by cell-free DNA testing among patients with metastatic breast, ovarian, pancreatic, or prostate cancer Bardia, A., Rich, T. A., Raymond, V. M., Fairclough, S. R., Sartor, A., Lilly, M. B., Nezami, M., Patel, S., Carneiro, B. A., Fan, A. C., Brufsky, A., Parker, B. A., Bridges, B. B., Agarwal, N., Maughan, B., Lanman, R. B., Cristofanilli, M. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.12097

View details for Web of Science ID 000442916004110